Back to User profile » Dr Xiaohui Wang
Papers published by Dr Xiaohui Wang:
Development and Validation of Nomogram to Predict Frailty for Older Patients Undergoing Abdominal Surgery
Zhang H, Xiao Y, Jin H, Wang X, Wang J
Clinical Interventions in Aging 2025, 20:2423-2435
Published Date: 6 December 2025
Survival Benefit of Lenvatinib Plus PD-1 Inhibitor with or Without HAIC in Advanced Hepatocellular Carcinoma Beyond Oligometastasis: a Multicenter Cohort Study
Wang M, Zhou Q, Li H, Liu M, Li R, Wang W, Wang X, Huang J, Duan F
ImmunoTargets and Therapy 2024, 13:447-459
Published Date: 9 September 2024
Hepatic Arterial Infusion Chemotherapy Combined Lenvatinib and PD-1 Inhibitor Showed Improved Survival for Infiltrative Hepatocellular Carcinoma: A Multicenter Cohort Study
Li R, Wang X, Li H, Wang M, Wang J, Wang W, Zhou Q
Journal of Hepatocellular Carcinoma 2024, 11:1727-1740
Published Date: 9 September 2024
Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study
Wang W, Li R, Li H, Wang M, Wang J, Wang X, Zhou Q
ImmunoTargets and Therapy 2024, 13:399-412
Published Date: 19 August 2024
Efficacy of Lenvatinib Combined with PD-1 Inhibitor versus Sorafenib and PD-1 Inhibitor with or Without TACE for Hepatocellular Carcinoma with Extrahepatic Metastasis
Duan WB, Wang XH, Zhang GC, He Z, Li SQ, Zhou J
ImmunoTargets and Therapy 2024, 13:247-258
Published Date: 16 May 2024
Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion
Yu Y, Wang XH, Hu WJ, Chen DH, Hu ZL, Li SQ
Journal of Hepatocellular Carcinoma 2024, 11:801-812
Published Date: 8 May 2024
Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients
Hu Z, Sun X, Mei J, Hu Z, Yang Z, Hou J, Fu Y, Wang X, Chen M
Journal of Hepatocellular Carcinoma 2022, 9:315-325
Published Date: 19 April 2022
